4//SEC Filing
O'Neill Julie 4
Accession 0000899866-18-000038
CIK 0000899866other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 7:16 PM ET
Size
8.7 KB
Accession
0000899866-18-000038
Insider Transaction Report
Form 4
O'Neill Julie
EVP. Global Operations
Transactions
- Sale
Common Stock, par value $.0001 per share
2018-02-08$116.31/sh−4,787$556,776→ 44,412 total - Award
Common Stock, par value $.0001 per share
2018-02-06+7,500→ 49,199 total - Award
Common Stock, par value $.0001 per share
2018-02-06+21,489→ 41,699 total
Footnotes (4)
- [F1]On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 21,489 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/3 of such shares vested on February 6, 2018 and 1/3 vest on each subsequent anniversary.
- [F2]On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 7,500 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/4 of such shares vested on February 6, 2018 and 1/4 vest on each subsequent anniversary.
- [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $116.00 - $116.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001630299
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 7:16 PM ET
- Size
- 8.7 KB